Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

BrainCool

0.53 SEK

+0.19 %

Less than 1K followers

BRAIN

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.19 %
+16.21 %
-9.80 %
+4.09 %
-41.13 %
-73.80 %
-66.22 %
-91.99 %
-69.77 %

BrainCool operates in the medical technology sector. The company develops products for medical cooling of the brain. The technology is developed as cooling pads that are applied to different parts of the patient's body, where the system controls body temperature. The products are used in the treatment of various serious conditions including stroke, cardiac arrest, as well as concussion and migraine. BrainCool was founded in 2010 and is headquartered in Lund.

Read more
Market cap
210.86M SEK
Turnover
145.89K SEK
Revenue
36.21M
EBIT %
-95.12 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
6/5
2026

Interim report Q1'26

20/5
2026

General meeting '26

12/8
2026

Interim report Q2'26

All
Webcasts
Press releases
ShowingAll content types
Press release2/25/2026, 7:30 AM

Ny jämförande analys baserad på COTTIS 1-studien bekräftar förbättrad neurologisk återhämtning med RhinoChill® System vid akut stroke

BrainCool
Press release2/20/2026, 7:45 AM

Resultaten från pilotfasen i PRINCESS 2-studien av RhinoChill® System publicerade i den vetenskapliga tidskriften Critical Care

BrainCool
Regulatory press release2/20/2026, 7:00 AM

Valberedningen utsedd inför BrainCools årsstämma 2026

BrainCool

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/18/2026, 7:30 AM

BrainCool AB (publ) – Bokslutskommuniké jan-dec 2025

BrainCool
Regulatory press release2/16/2026, 7:00 AM

BrainCool erhåller order på BrainCool™ System från bolagets globala distributör till ett värde uppgående till minst SEK 39 miljoner

BrainCool
Regulatory press release2/12/2026, 7:00 AM

BrainCool bjuder in till webcast med bolagets nya vd

BrainCool
Press release2/5/2026, 7:00 AM

BrainCool har erhållit ordrar på engångsprodukter till ett värde av SEK 9 miljoner

BrainCool
Press release1/23/2026, 7:00 AM

BrainCool inkluderar patient till COTTIS 2-studien av RhinoChill®

BrainCool
Regulatory press release12/19/2025, 7:30 AM

BrainCool offentliggör utfallet i övertecknad företrädesemissionen och beslutar om en övertilldelningsemission

BrainCool
Regulatory press release12/16/2025, 7:00 AM

BrainCool utser Anna Lindström till ny vd

BrainCool
Regulatory press release12/16/2025, 7:00 AM

BrainCool appoints Anna Lindström as new CEO

BrainCool
Regulatory press release12/12/2025, 7:00 AM

BrainCool erhåller ett bidragstillskott från EU på cirka 6 miljoner SEK för COTTIS 2-studien och förstärker sitt kliniska team

BrainCool
Regulatory press release12/12/2025, 7:00 AM

BrainCool receives supplementary EU grant of approximately SEK 6 million for the COTTIS 2 study and strengthens its clinical team

BrainCool
Press release12/11/2025, 10:41 AM

BioStock: BrainCool växlar upp med säkerställd emission – siktar på svarta siffror

BrainCool
Press release12/9/2025, 9:03 AM

BioStock: BrainCool pratar emission och vägen framåt

BrainCool
Regulatory press release12/9/2025, 7:00 AM

BrainCool ansöker om MDR-godkännande för BrainCool System

BrainCool
Press release12/8/2025, 6:40 AM

BioStock: BioStock Investor Pitch: BrainCool

BrainCool
Press release12/4/2025, 10:01 AM

BioStock: BrainCools vd kommenterar tillväxt och emission

BrainCool
Regulatory press release12/1/2025, 2:53 PM

BrainCool publishes information document regarding rights issue

BrainCool
Regulatory press release12/1/2025, 2:53 PM

BrainCool offentliggör informationsdokument avseende företrädesemission

BrainCool
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.